Recruiting

Observational Study

Sponsor:

Sofwave Medical LTD

Code:

NCT07723664

Conditions

Facial Wrinkles

Jawline Contour

Skin Laxity

Eligibility Criteria

Sex: All

Age: 40 - 55

Healthy Volunteers: Accepted

Interventions

SofWave

Study Details

Brief summary:

Non-randomized single-arm prospective clinical study.

Conditions

Facial Wrinkles

Jawline Contour

Skin Laxity

Study ID

NCT07723664

Start date

Jul 20, 2026

Status verified date

Nov, 2026

Completion date

Jul 15, 2027

Anticipated

Primary completion date

Jul 15, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 40 - 55

Healthy Volunteers: Accepted

Inclusion Criteria:

1. Healthy female and male subjects between the ages 40-55.
2. Non-Smoker.
3. Fitzpatrick skin type I-VI.
4. Desire to lift facial lax skin, neck and/or submental and/or improve facial wrinkles appearance.
5. Presence of mild to moderate laxity in the lower face and submental area.
6. Able and willing to comply with all visits, treatments and evaluation schedules and requirements.
7. Able to understand and provide written Informed Consent.
8. Women of child-bearing age are required to be using a reliable method of birth control at least 3 months prior to study enrollment.
9. Subject agrees not to undergo any other facial cosmetic treatment for a period of 3 months following last SofWave treatment.
10. Stable weight over the last 12 weeks and throughout the duration of the study.
11. Subjects agree to adhere to safe sun practices and daily use of broad-spectrum sunscreen SPF 30+.
12. Male subjects with facial hair in the treatment area are willing to trim or shave as needed to allow consistent standardized photography.

\-

Exclusion Criteria:

1. Pregnant or planning to become pregnant, having given birth less than 3 months ago, and/or breast feeding.
2. Presence of any active systemic or local infections.
3. Open wounds or lesions within the intended to treat area.
4. Tattoo or former tattoo at or near treatment area.
5. Presence of active local skin disease that may alter wound healing.
6. Uncontrolled diabetes mellitus.
7. Skin cancer in the area to be treated. History of any other non-melanoma skin cancers in the past 5 years within the treatment area (head and neck).
8. Severe solar elastosis.
9. History of smoking in the past 10 years.
10. History of chronic drug or alcohol abuse.
11. Excessive subcutaneous fat on the cheeks.
12. Significant scarring in the area to be treated or history of keloids.
13. Severe or cystic facial acne, and/or Accutane use during the past 6 months.
14. Pacemakers and electronic device implants in the treated area.
15. Presence of a metal stent or implant in the facial area (dental implants and/or braces are not excluded).
16. Inability to understand the protocol or to provide a signed informed consent.
17. History of cosmetic treatments in the area to be treated including:

  • Chemical peels, microneedling, dermabrasion, energy-based devices, or laser treatments in the past 6 months
  • Injectable filler treatments in the past 6 months
  • Injectable neuromodulator treatment in the past 4 months
18. Cosmetic surgical procedures in the treatment area, including but not limited to facelift in the past 12 months.
19. Taking anti-platelet or anti-coagulant within the past 2 weeks.
20. Ongoing use of psychiatric medication; taking psychiatric drugs within the past 2 weeks.
21. As per the investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study.

\-

Study Design

Enrollment

30 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Experimental: lax tissue

Interventions

SofWave

The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues

Primary outcome measure

  • Evaluate the clinical efficacy of the treatment for lower face and upper neck rejuvenation [ Time Frame: 12 weeks post treatment follow-up visit ]
  • Lower face and upper neck rejuvenation [ Time Frame: 12 weeks post treatment follow-up visit ]

Central Contacts and Locations

Central contacts

Locations

Dermatology & Laser Surgery Center

Recruiting

Houston, Texas, United States, 77004

Contacts

Principal Investigator:

Paul Friedman, MD

More Information

Sponsor

Sofwave Medical LTD

Last update posted

Nov 18, 2026

Last verified

Nov, 2026

Keywords

  • lower face
  • upper neck
  • submental
  • facial wrinkles
  • jawline contour
  • skin laxity

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Sofwave Medical LTD on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.